Fighting fatigue: Acupuncture to be trialled for cancer patients

April 7, 2010, University of Western Sydney

( -- Women being treated for breast cancer who are experiencing fatigue are invited to join a clinical trial to determine if acupuncture could alleviate their symptoms.

Associate Professor Caroline Smith, from the University of Western Sydney's Complementary Medicine Research Centre (CompleMED) says fatigue during cancer treatments is common.

"Up to 99 percent of people report a lack of energy during their ," says Associate Professor Smith.
"Up to 40 percent continue to experience fatigue for many years after their cancer treatment has concluded."

Associate Professor Smith says adjuvant chemotherapy has increased the survival rate for cancer patients in the last 20 years, but it can be associated with multiple side effects which can include nausea, vomiting and fatigue.

"Treating cancer related fatigue usually includes ruling out causes such as , but often no specific cause or adequate treatment is found," she says.

"Acupuncture has shown promise for treating cancer related fatigue in small scale trials overseas and this pilot trial - if successful - will help lay the foundation for a future large scale clinical trial."

Acupuncture is a method used in Traditional Chinese Medicine which involves the insertion of very fine sterile acupuncture needles into specific points on the body.

Women participating in the six week trial will be randomly selected to receive the acupuncture treatment, or receive a 'placebo' or 'fake' non-reactive treatment, or be assigned to the control group and not receive treatment at all.

At the end of the trial, those in the control group may choose to receive a course of acupuncture treatment.

The trial is open to women aged 18 to 70 years who have been diagnosed with ; have completed treatment at least one month before the trial; and are currently experiencing moderate levels of .

Those in the acupuncture or placebo treatment groups will be required to attend a clinic at the UWS Campbelltown campus or at another Sydney location.

At the conclusion of each treatment session participants will be asked to complete a short questionnaire. At the end of the trial a selection of participants will be interviewed to provide greater insight into the effects of the trial on their health and well being.

The clinical trial will be conducted in collaboration with Professor Jane Ussher and Associate Professor Janette Perz both from the UWS School of Pyschology.

Related Stories

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.